Group C strep refers to bacteria in the Streptococcus dysgalactiae species complex, which causes infections such as pharyngitis, skin abscesses, and occasionally invasive disease. Unlike Group A strep, it rarely causes rheumatic fever and is less commonly diagnosed.
These bacteria belong to Lancefield group C, a classification based on cell wall carbohydrates. They are Gram-positive cocci that grow in chains and are typically transmitted through close contact, often from animals or contaminated food. They are not associated with the same post-infectious complications as Group A strep, such as acute rheumatic fever or post-streptococcal glomerulonephritis.
Group C strep accounts for fewer than 5% of all streptococcal pharyngitis cases in adults and children. Most infections are mild, but severe presentations-such as sepsis or necrotizing fasciitis-can occur, especially in immunocompromised individuals.
Group C strep enters the body through mucous membranes or broken skin. Once inside, it multiplies rapidly and releases toxins that damage host tissues. The immune system responds with inflammation, leading to symptoms like sore throat, fever, and swollen lymph nodes.
Unlike Group A strep, which produces streptolysin O and other virulence factors linked to autoimmune sequelae, Group C strep lacks the specific M protein variants tied to rheumatic fever. This biological difference explains why Group C infections do not trigger the same long-term inflammatory conditions.
Diagnosis relies on culture or PCR testing. Standard rapid antigen detection tests (RADTs) used for Group A strep are not validated for Group C strep. A negative RADT does not rule out Group C infection-clinicians must consider alternative testing methods when symptoms persist despite negative results.
Group C strep includes several closely related species, primarily Streptococcus dysgalactiae subsp. equisimilis. These organisms are commonly found in livestock, particularly cattle and horses. Human exposure often occurs during farming, veterinary work, or handling raw meat.
| Type | Common Source | Typical Infection | Testing Method |
|---|---|---|---|
| Streptococcus dysgalactiae | Cattle, horses | Pharyngitis, skin infections | Throat culture, PCR |
| Streptococcus equi | Horses | Equine respiratory disease | PCR, serology |
| Streptococcus zooepidemicus | Various animals | Necrotizing soft tissue infections | Blood culture, molecular testing |
Outbreaks have been documented in agricultural settings. A 2019 study in the Journal of Clinical Microbiology reported a cluster of Group C strep pharyngitis among farm workers in Wisconsin, traced to direct contact with infected cows. All patients recovered after penicillin therapy, highlighting the zoonotic potential of these pathogens.
Group C strep is not used therapeutically or industrially. Its presence in clinical settings is purely diagnostic and pathogenic. However, confusion arises because some rapid strep tests detect only Group A strep, leading to missed diagnoses.
Healthcare providers may misattribute persistent sore throat to viral causes when Group C strep is actually responsible. This misdiagnosis delays appropriate antibiotic treatment and increases transmission risk in schools or households.
A 2021 review in Clinical Infectious Diseases noted that up to 12% of patients with clinically suspected strep throat had negative Group A strep tests but positive results for Group C or Group G strep. These cases were initially treated with antivirals or symptomatic care, prolonging illness.
Group C strep is frequently mistaken for Group A strep due to overlapping symptoms. Both can cause fever, sore throat, and tonsillar exudate. However, Group C strep is less likely to cause petechiae on the palate or strawberry tongue.
Another misconception is that Group C strep causes scarlet fever. This condition is exclusively linked to Group A strep strains producing erythrogenic toxin. Group C strep does not produce this toxin and therefore cannot cause scarlet fever.
Some clinicians assume that a negative rapid test rules out strep infection. This is incorrect. Rapid antigen tests are designed for Group A strep only. A negative result does not exclude Group C or Group G strep. When symptoms persist, throat culture or nucleic acid amplification testing (NAAT) should be performed.
In 2020, a 14-year-old boy presented with a 5-day history of sore throat, fever (38.9°C), and swollen neck glands. He tested negative on a rapid Group A strep test. His primary care provider assumed a viral etiology and prescribed rest and hydration.
After four days of worsening symptoms, he returned with a temperature of 39.4°C and difficulty swallowing. A throat swab was sent for culture. Two days later, it grew Streptococcus dysgalactiae, identified as Lancefield group C. He was started on oral penicillin V, and symptoms resolved within 48 hours.
This case illustrates the importance of considering non-Group A strep pathogens in persistent pharyngitis. Without culture confirmation, the infection would have gone untreated, increasing the risk of complications such as peritonsillar abscess or secondary spread.
I encountered a similar case while working in a rural clinic. A teacher developed a severe sore throat after helping a local farmer deliver a calf. Initial testing was negative for Group A strep. After referral to an infectious disease specialist, NAAT testing confirmed Group C strep. The patient had no known animal exposure history until asked directly-highlighting the need for detailed exposure questioning.
Group C strep is a bacterial pathogen that causes pharyngitis and skin infections but differs from Group A strep in epidemiology, complications, and testing requirements. It is not responsible for rheumatic fever or scarlet fever. Accurate diagnosis depends on culture or molecular testing-not rapid antigen tests designed for Group A strep.